These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 772555)

  • 1. The suppression of factor VIII antibodies in haemophilia.
    Dormandy KM; Sultan Y
    Pathol Biol (Paris); 1975 Dec; 23 suppl():17-23. PubMed ID: 772555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of haemophilia A with antibodies--the effect of combined treatment with factor VIII, hydrocortisone and cyclophosphamide.
    Hedner U; Tengborn L
    Thromb Haemost; 1985 Dec; 54(4):776-9. PubMed ID: 3937274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of patients with hemophilia A having antibodies to factor VIII].
    Lopaciuk S; Ziemski JM
    Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
    Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance of factor VIII antibodies upon frequent administration of factor VIII.
    Mauser-Bunschoten EP; Roosendaal G; Bruin M; van Dijken PJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):533-7. PubMed ID: 1714856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
    Nilsson IM; Berntorp E; Zettervall O
    N Engl J Med; 1988 Apr; 318(15):947-50. PubMed ID: 3127711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of factor VIII antibody in haemophilic monozygotic twins. European Study Group of Factor VIII Antibody.
    Scand J Haematol; 1979 Jul; 23(1):64-8. PubMed ID: 573920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of immunosuppression in a severe haemophilia B patient with specific antibody.
    Allain JP; Frommel D
    Thromb Haemost; 1976 Aug; 36(1):86-9. PubMed ID: 1036830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
    Lechner K; Nowotny C; Krinninger B; Zegner M; Deutsch E
    Thromb Haemost; 1979 Feb; 40(3):478-85. PubMed ID: 425062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired haemophilia.
    Mehta JB; Mehta S
    J Assoc Physicians India; 1990 Dec; 38(12):895-6. PubMed ID: 2128938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab in the treatment of high responding inhibitors in severe haemophilia A.
    Moschovi M; Aronis S; Trimis G; Platokouki H; Salavoura K; Tzortzatou-Stathopoulou F
    Haemophilia; 2006 Jan; 12(1):95-9. PubMed ID: 16409183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response induced by porcine factor VIII in severe hemophiliacs with antibody to F VIII.
    Verroust F; Allain JP
    Thromb Haemost; 1982 Oct; 48(2):238. PubMed ID: 6817447
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy.
    Toepfer M; Rommel F; Sitter T; Spannagl M; Held E; Schramm W; Schiffl H
    Thromb Haemost; 1998 Dec; 80(6):1035-6. PubMed ID: 9869185
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
    Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
    Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.